Pfizer plans to close an R&D facility in the UK

— filed under: , ,

Article from (1st Februar 2011). As part of its ongoing effort to brace for the loss of the Lipitor patent, Pfizer now plans to close an R&D facility in Sandwick, Kent in the UK, which employs 2,400 jobs and was where Viagra was born.

The drugmaker will also shift some operations from its Groton, Connecticut R&D facility in the US to its Cambridge, Massachusetts site, which is being expanded, as it moves to slash $1.5 billion from R&D spending.


Read more on:


Document Actions